Banner Image for Directory

Directory



Chow Wan Cheng

Clinical Associate Professor

Vice Dean, Office of Academic and Clinical Development, Duke-NUS Medical School

Email

Bio Research Publications

Education Qualifications: MBBS (Spore), MMed (Int Med), MRCP(UK), FAMS

Clinical Associate Professor Chow Wan Cheng graduated from the Faculty of Medicine, National University of Singapore in 1985.  She was further trained in Hepatology as a Clinical and Research fellow in Service d’Hepatologie, Hopital Beaujon, Clichy, France from the year 1996 to 1997.  Her area of specialty is hepatology, in particular viral hepatitis and liver transplantation. 

Clinical Associate Professor Chow is currently a Senior Consultant in the Department of Gastroenterology and Hepatology, Singapore General Hospital and Clinical Associate Professor of the NUS Yong Loo Lin School of Medicine as well as Adjunct Associate Professor of Duke-NUS Medical School. She is currently Chairman for the Division of Medicine in SGH.

 

Professional Appointments and Committee Memberships:

  • Senior Consultant, Gastroenterology & Hepatology, Singapore General Hospital
  • Member, Clinical Practice Guidelines on Cancer Screening, MOH, Singapore (2008)
  • Member, Specialist Training Committee for Gastroenterology, Ministry of Health (MOH), Singapore (2006 - Present)
  • Member, SingHealth Clinical Advisory Panel for Business Development (2005)
  • Member, Pharmocovivgilance Advisory Committee, Health Sciences Authority (HSA), Singapore (2003 - Present)

Awards:

  • CEO Service Award Winner (2005)
  • Best Poster Award, Asia Pacific Association for the Study of the Liver 14th Biennial Conference (2004)
  • Seah Cheng Siang Book Prize (Best Paper Award), Chapter of Physicians, Academy of Medicine, Singapore in conjunction with the 15th Annual Scientific Meeting of the GESS, Combined Scientific Meeting (1999)

Selected Publications:

Inborn errors of metabolism in Singapore, IK Tan, LF Chio, FC Loh, I Ng, BC Ooi, WC Chow et al, Journal of Inherited Metabolic Diseases, 1995, vol. 18

Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans, R Guan, HS Ng, KM Fock, KY Ho, I Yap, JY Kang, WC Chow, CN Chew, C Ng, CJ Teo, et al, Southeast Asian J Trop Med Public Health 1995, 26(2):268-78.

Recurrent Hyperammonaemic Encephalopathy due to Citrullinaemia in a 52-year man WC Chow, HS Ng, IK Tan, TY Thum, Journal of Gastroenterology and Hepatology, 1996, 11(7):621-5.

Acute Viral Hepatitis E: Clinical and Serological Studies in Singapore, Chow WC, Lee ASG, Lim GK, Cheong WK, R Chong, Tan CK, Yap CK, Oon CJ, Ng HS, Journal of Clinical Gastroenterology, 1997, 24(4):235-8.

Retreatment with interferon alfa of patients with chronic hepatitis C, WC Chow, N Boyer, M Pouteau, C Castelnau, M Martinot-Peignoux, VMartins-Amado, et al, Hepatology 1998, 27(4): 1144-8.

Antibodies to Ro / La, Cenp-B and snRNPs antigens in autoimmune hepatitsi of North America versus asia: pattern of immunofluorescence, ELISA reactivities and HLA association. Parveen S, Morshed SA, Arima K, Nishioka M, Cazja AJ, Chow WC, Ng HS., Dig Dis Sci 1998, 43(60:1322-31.

Hepatitis C: Retreatment and treatment of patients with renal failure, Wan-Cheng Chow., J Gastroenterol Hepatol 2000, 15(S2):E152-5.

Wild –type and ‘a’ epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigens and antibody,      Steven J Mesenas, Wan C Chow, Yi Zhao, Gek K Lim, Chong J Oon, Han S Ng, J Gastroenterol Hepatol 2002, 17:148-50

Blue rubber bleb nevus syndrome: a clinical spectrum with correlation between c utaneous and gastrointestinal manifestations, Chin-Ho Wong, Yu-Meng Tan, Wan-Cheng Chow, Puay-Hoon Tan, Wai-Keong Wong. J Gastroentrol Hepatol 2003, 18:1000-2.  

Lamivudine for patients with chronic hepatitis B and advanced liver disease, Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. New Engl J Med 2004, 351(15):1521-31.

Hepatitis B Reactivation in a patients receiving radiolabeled rituximab. Soong YL, Lee MK , Lui HF, Chow WC, Tao M, Li Er Loong S Ann Hematol 2005, 84(1):61-2.

Peginterferon Alfa-2a, Lamivudine, and the Combination for HbeAg-Positive Chronic Hepatitis B, George KK Lau, T Piratvisuth, KX Luo, P Marcellin, S Thongsawat, G Cooksley, E Gane, M W. Fried, WC Chow, SW Paik, WY Chang, T Berg, R Flisiak, P McCloud, N Pluck, The New England Journal of Medicine 2005, 352 (26): 2682-2695.